Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for HFE and iron overload.

John Ombiga1, Leon A Adams, Kevin Tang

  • 1Department of Gastroenterology, Fremantle Hospital, Fremantle, Western Australia, Australia.

Seminars in Liver Disease
|November 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Supervised, Online, Home-Based Eccentric Resistance Exercise Program for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology research·2026
Same author

Haemochromatosis - a modern clinician's guide.

Internal medicine journal·2026
Same author

Arthritis and High Alcohol Intake at Diagnosis Increase Future Risk of Hepatocellular Carcinoma in <i>HFE</i> Hemochromatosis.

Gastro hep advances·2026
Same author

Reassessing Ferritin Levels in Healthy Older Adults: Updated Reference Ranges and Associated Health Outcomes.

Archives of pathology & laboratory medicine·2026
Same author

National survey of real-world treatment patterns for early- and intermediate-stage hepatocellular carcinoma reveals wide variation across Australian states.

Internal medicine journal·2026
Same author

Federal Healthcare Legislation that Promoted the Digitalization of Medicine and the Impact on Healthcare Delivery in 2025.

Applied clinical informatics·2026
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Type 1 hereditary hemochromatosis, a genetic iron overload disorder, requires early detection via iron tests and HFE gene analysis. Timely phlebotomy can prevent severe complications like cirrhosis and normalize lifespan.

Area of Science:

  • Genetics
  • Internal Medicine
  • Public Health

Background:

  • Type 1 hereditary hemochromatosis is a prevalent genetic disorder characterized by iron overload.
  • It is caused by homozygosity for the C282Y HFE gene mutation and can lead to progressive, fatal outcomes.
  • Early intervention, including phlebotomy before cirrhosis onset, significantly improves prognosis and life expectancy.

Purpose of the Study:

  • To outline the diagnostic methods for Type 1 hereditary hemochromatosis.
  • To discuss current screening strategies, focusing on high-risk populations over general screening.
  • To identify barriers to widespread genetic screening implementation.

Main Methods:

  • Biochemical testing for iron overload, specifically serum transferrin saturation.

Related Experiment Videos

  • Genetic testing to identify C282Y homozygosity in the HFE gene.
  • Review of current screening guidelines and rationale for targeting specific groups.

    • Main Results:

    • Type 1 hereditary hemochromatosis is effectively diagnosed using iron overload markers and HFE gene testing.
    • Current screening prioritizes first-degree relatives and symptomatic individuals, avoiding general population screening.
    • Uncertainties in disease natural history, penetrance, and management hinder broader screening adoption.

    Conclusions:

    • Early detection and treatment of hereditary hemochromatosis are crucial for preventing severe health consequences.
    • Targeted screening of high-risk groups is the current standard due to unresolved issues with general population screening.
    • Further research and ethical considerations are necessary before widespread genetic screening can be implemented.